Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

ClinicalTrials.gov ID: NCT07705555

Public ClinicalTrials.gov record NCT07705555. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Masked, Multicenter, 3-Arm, Pivotal Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal (IVT) MK-8748 Compared With Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Researchers are looking for new ways to treat diabetic macular edema (DME). In this trial, researchers want to learn if a trial medicine called MK-8748 can treat DME. An available standard (usual) treatment for DME is aflibercept. However, standard treatments such as aflibercept may not work for every person. The main goal of this trial is to learn if MK-8748 works as well as aflibercept to treat DME.

Study identification

NCT ID
NCT07705555
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
960 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 27, 2026 (Actual)
Primary completion
Oct 31, 2028 (Estimated)
Completion
Oct 31, 2029 (Estimated)
Last update posted
Oct 20, 2026

2026 – 2029

United States locations

U.S. sites
24
U.S. states
14
U.S. cities
24
Facility City State ZIP Site status
Global Research Management ( Site 0066) Glendale California 91204 Recruiting
Retinal Consultants Medical Group ( Site 0013) Sacramento California 95825 Recruiting
Retina Specialists of Colorado ( Site 0068) Denver Colorado 80222 Recruiting
Retina Consultants ( Site 0065) Manchester Connecticut 06042 Recruiting
Vitreo Retinal Associates ( Site 0042) Gainesville Florida 32607 Recruiting
Retina Care Specialists ( Site 0095) Palm Beach Gardens Florida 33410 Recruiting
Retina Vitreous Associates of Florida ( Site 0034) Tampa Florida 33617 Recruiting
Retina Associates LLC ( Site 0024) Lenexa Kansas 66215 Recruiting
Mid Atlantic Retina ( Site 0062) Hagerstown Maryland 21740 Recruiting
Retina Specialists ( Site 0074) Towson Maryland 21204 Recruiting
Mississippi Retina Associates, P.A. ( Site 0061) Madison Mississippi 39110 Recruiting
Envision Ocular, LLC ( Site 0039) Bloomfield New Jersey 07003 Recruiting
Retina Associates of Western NY, PC ( Site 0038) Rochester New York 14620 Recruiting
North Carolina Retina Associates ( Site 0064) Wake Forest North Carolina 27587 Recruiting
Charleston Neuroscience Institute ( Site 0087) Bluffton South Carolina 29910 Recruiting
Palmetto Retina Center ( Site 0063) Florence South Carolina 29501 Recruiting
Palmetto Retina Center ( Site 0014) West Columbia South Carolina 29169 Recruiting
Southeastern Retina Associates PC ( Site 0071) Johnson City Tennessee 37604 Recruiting
Southeastern Retina Associates PC ( Site 0018) Knoxville Tennessee 37922-3572 Recruiting
Austin Retina Associates ( Site 0008) Austin Texas 78705 Recruiting
Retina Consultants of Texas ( Site 0001) Bellaire Texas 77401 Recruiting
Austin Retina Associates ( Site 0080) San Marcos Texas 78666 Recruiting
Retina Consultants of Texas ( Site 0029) Schertz Texas 78154 Recruiting
Retina Consultants ( Site 0104) Charleston West Virginia 25301 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07705555, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2026 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT07705555 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →